Pneumococcal Conjugate Vaccines Are Protective Against Respiratory Syncytial Virus Hospitalizations in Infants: A Population-Based Observational Study

BACKGROUND: Pneumococcal conjugate vaccines (PCV) reduced the risk of respiratory syncytial virus (RSV) in a randomized clinical trial. We aimed to assess the real-world effectiveness of PCV on RSV-hospitalizations among Western Australian infants. METHODS: We conducted a population-based cohort stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Le, Huong, Gidding, Heather, Blyth, Christopher C, Richmond, Peter, Moore, Hannah C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135427/
https://www.ncbi.nlm.nih.gov/pubmed/37125230
http://dx.doi.org/10.1093/ofid/ofad199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135427/
https://www.ncbi.nlm.nih.gov/pubmed/37125230
http://dx.doi.org/10.1093/ofid/ofad199

Ejemplares similares